Nephroureteral Stent Market Report Overview
- Request a Free sample to learn more about this report
The global nephroureteral stent market size was USD 2.364 billion in 2021 and is expected to reach USD 3.665 billion in 2028, exhibiting a CAGR of 6.0% during the forecast period.
Nephrostomy and ureteral stenting assist in reestablishing urine flow through obstructed ureters and restore kidney function. Urine is transported from the kidneys to the bladder through ureters, which are long, narrow tubes. Numerous causes might affect them to become blocked, preventing urine flow. To re-establish urine flow, the doctor might utilize imaging guidance to insert a small, flexible tube known as a stent into the ureter.
Whilst ureteral stents are inserted into ureters during a surgical technique called ureteral stenting, their use is increasing. The catheter is implanted with one end in the urine bladder and the other in the kidney. To keep the gadget from dislocating, the ends could be coiled. Most frequently, the stent is left in place until the obstruction is removed. As a result, the market share of ureteral stents has probably increased recently. The ureteral stent market demand analysis is increasing during the forecast period from 2021 to 2028 due to the innovative interface platforms available in the market for stent case treatment and patient safety that have been helpful for both doctors and patients.
COVID-19 Impact: Halt In The Auxiliary Medical Processes To Impede The Market Demand
The global COVID-19 pandemic has been unprecedented and staggering, with nephroureteral stent market experiencing lower-than-anticipatedhigher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
The effects of the COVID-19 pandemic are already being felt on a global level, and the global cubicles and partition market were significantly influenced. The outbreak of COVID-19 had a negative impact on several markets. Various countries went into lockdown. With the sudden pandemic, all kinds of businesses observed disruptions. With many restrictions during the pandemic, various industries were impacted and the healthcare industry was one of them. The severity of the pandemic resulted in an increase in the number of COVID-19 cases shifting the focus of entire healthcare towards itself negatively affecting the demand for the product and affecting the market growth.
Latest Trends
"Rising Sedentary Lifestyle To Contribute To Increased Medical Problems"
The upsurge in kidney disorders, increase in the geriatric population, increase in urbanization, and increase in sedentary lifestyles are the dominant elements driving the market growth during the forecast period. These factors are influencing the market growth because they have a detrimental effect on the kidney's ability to function normally. Last but not least, a lengthy homestay has a number of negative effects on patients, including weight gain and physical inactivity, which may increase their risk of kidney stones, combined with poor dietary habits and fluid intake, rising obesity rates, and an increased in the number of cases of metabolic disorders, which may accelerate the nephroureteral stent market growth.
Nephroureteral Stent Market Segmentation
- Request a Free sample to learn more about this report
- By Type Analysis
According to type, the market can be segmented into Sealing bracket, Closed support, Double J tube, Multi loop J tube. The Sealing Bracket segment holds the majority of the sector by type.
- By Application Analysis
Based on application, the market can be divided into Hospital, Outpatient Operating Center. By application of nephroureteral stent, the hospital segment is the leading segment in the market.
Driving Factors
"Emerging Prevalence Of Urological Disorders To Increase The Demand"
One of the key reasons propelling the market is the rising prevalence of urological and kidney-related illnesses. Patients with kidney stones and urinary incontinence can benefit from the use of nephroureteral stents for a number of disorders. These stents enable residual fragment flow without ureter obstruction. Additionally, ureteral stents are necessary before, during, or after therapy due to the incidence of prostate cancer, tumors, or constriction or scarring of the ureter. In reality, ureteral stents are typically required for all urological and kidney-related treatments in order to allow for appropriate ureteral healing, hence the rising prevalence of urological disorders is expected to raise nephroureteral stent market share.
"Innovations And Technological Advancement To Drive The Market Growth"
The use of biodegradable materials and antibacterial coatings in ureteral stents, among other technological innovations, has resulted in effective and improved outcomes for kidney and urine problems. Companies take an active role in developing products that lessen tissue irritation, stent migration, and ureterovesical reflux during procedures. For instance, Coloplast's Polyurethane and Silicone double-loop ureteral stents, which are biocompatible and flexible polymer ureteral stents, are widely used by professionals for long-term implantation during urological surgery. During the projected period, this is anticipated to have a favorable effect on nephroureteral market growth.
Restraining Factors
"High Cost Of Procedure And Procedural Complexity To Hinder The Market Expansion"
The significant parameters that could limit the market growth for ureteral stents include the complicated stent placement procedure, a shortage of skilled surgeons, complications following stent removal, and discomfort associated with living with a ureteral stent and its side effects, such as increased frequency of urination and urgency to urinate. Additionally, owing to the high cost of operation and procedural intricacy, only the affluent can access the market to restrict the nehroureteral stent market size.
Nephroureteral Stent Market Regional Insights
- Request a Free sample to learn more about this report
"North America Region To Dominate Due To Increased Prevalence Of Sedentary Lifestyle"
The market is dominated by North America, which holds the largest revenue share and is expected to continue in the forecasted period. The market in North America is primarily driven by sedentary lifestyle-related urological and kidney-related illnesses like kidney stones, chronic kidney disease, and urine incontinence. Over the forecast period, Asia Pacific is anticipated to experience the second-highest growth. An aging population with kidney-related illnesses, an increase in urological treatments, and better healthcare infrastructure in emerging economies are the primary market drivers.
Key Industry Players
"Key Players Focus on Partnerships to Gain a Competitive Advantage "
Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.
List of Market Players Profiled
- Boston Scientific (U.S.)
- C. R. Bard (U.S.)
- Cook Medical (U.S.)
- Medline Industries (U.S.)
- Pnn Medical (Denmark)
- Allium Medical (Israel)
- B. Braun (Germany)
- Dextronix (U.S.)
Report Coverage
This research profiles a report with extensive studies that take into description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 2.364 Billion in 2022 |
Market Size Value By |
US$ 3.665 Billion by 2028 |
Growth Rate |
CAGR of 6% from 2022 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2022 |
Historical Data Available |
Yes |
Segments Covered |
Type & Application |
Regional Scope |
Global |
Frequently Asked Questions
-
What value is the nephroureteral stent market expected to touch by 2028?
The nephroureteral stent market is expected to touch USD 3.665 billion by 2028.
-
What CAGR is the nephroureteral stent market expected to exhibit during 2022-2028?
The nephroureteral stent market is expected to exhibit a CAGR of 6.0% over 2022-2028.
-
Which are the driving factors of the nephroureteral stent market?
The major driving factors of the nephroureteral stent market are growing sedentary lifestyle and innovations and technological advancements.
-
Which are the top companies operating in the nephroureteral stent market?
Some of the major companies are Boston Scientific (U.S.), C. R. Bard (U.S.), Cook Medical (U.S.), Medline Industries (U.S.) and Pnn Medical (Denmark) are the top companies operating in the nephroureteral stent market.